Skip to Content

What type of drug is Bavencio?

Medically reviewed by Last updated on Jul 2, 2020.

Official Answer


Bavencio (avelumab) is a programmed death ligand-1 (PD-L1) blocking antibody.

Bavencio targets the PD-L1 receptors, which are protein receptors on cell surfaces. When Bavencio blocks PD-L1, it 'turns on' the ability of cancer-fighting cells such as T-cells to attack and kill tumors.

Learn More: Checkpoint Inhibitors & Advanced Cancers: A Health Care Professional's Guide

Bavencio is used for the treatment of:

Drug Information

Related Support Groups